Advertisement Pharmaceutical Business review - Page 68 of 5270 -
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
April 22, 2026

Health Canada approves Biocon’s two denosumab biosimilars

Biocon has received a Notice of Compliance from Health Canada for Bosaya (denosumab) and Vevzuo (denosumab), both biosimilars referencing Prolia and Xgeva, respectively.

Continue
The approval follows comprehensive data supporting Bosaya and Vevzuo’s similarity. Credit: SmartPhotoLab / Shutterstock.com.
April 22, 2026

BioAegis and Prenosis partner for inflammatory disease therapies

Prenosis incorporates multi-dimensional biological data and machine learning to detect clinically meaningful patterns in complex diseases. Credit: Komsan Loonprom / Shutterstock.com.
April 21, 2026

Pfizer and Astellas secure FDA priority review for Padcev MIBC combo therapy

The submission was based on Phase III EV-304 trial data. Credit: Pickadook / Shutterstock.com.

Contracts

January 23, 2025

Kamada to supply immune globulin products in Latin America

KAMRAB must be administered alongside a complete rabies vaccine regimen. Credit: Nappy on Unsplash.

Bavarian Nordic secures $156.8m US vaccine deal

Boehringer Ingelheim receives EC conditional marketing approval for spesolimab

Marinus Pharmaceuticals signs collaboration agreement with Tenacia Biotechnology

Deals

Deals January 20, 2025

Fermion and Simcere to partner on development of pain treatment drug

Pharmaceutical Business Review

WuXi Biologics and Sino Biopharm collaborate on monoclonal antibody discovery

Merck enhances ophthalmology portfolio with EyeBio acquisition

Biocon signs licensing and supply deal for diabetes drug in Brazil

Popular

  1. Asahi Kasei acquires German company Aicuris
  2. UCB to purchase Neurona and NRTX-1001 for $1.15bn
  3. MSD secures EC approval for Enflonsia to prevent infant RSV infection
  4. Aligos and Xiamen Amoytop sign deal for HBV therapy
  5. Daiichi Sankyo and Interna partner for MNM-targeted delivery solutions

PRESS RELEASES

SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma and SHL Medical Enhance Home-Based Large-Volume Injections for Patients
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
SCHOTT Pharma Launches Ready-to-Use Polymer Cartridge
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Accelerating Self-Administration and Homecare: SCHOTT Pharma Launches Large-Volume Prefillable Glass Syringe
Pharmaceutical Business Review
Christian Mias to Succeed Andreas Reisse as CEO of SCHOTT Pharma
Pharmaceutical Business Review
LTS completes acquisition of Renaissance Lakewood, expanding global CDMO capabilities

Suppliers

Whitepapers

Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Smoothly Through the Production Process: EVERIC™ Strong/Smooth Test
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Strengths and Weaknesses of Different Prefilled Syringes for Injections in Hospitals: A Case Study by Niklas Niederwieser and Patrick Gallagher SCHOTT AG
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography
Tracking the Cracking: How to Optimise Pharma Fill-and-Finish Processes by Use of Strength Testing and Fractography